Hakutulokset - Greuter, Marjolein J.E.

Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program Tekijä Vleugels, Jasper L. A., Greuter, Marjolein J. E., Hazewinkel, Yark, Coupé, Veerle M. H., Dekker, Evelien

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Resilience of a FIT screening programme against screening fatigue: a modelling study Tekijä Greuter, Marjolein J. E., Berkhof, Johannes, Canfell, Karen, Lew, Jie-Bin, Dekker, Evelien, Coupé, Veerle M. H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening Tekijä Bronzwaer, Maxime E. S., Greuter, Marjolein J. E., Bleijenberg, Arne G. C., IJspeert, Joep E. G., Dekker, Evelien, Coupé, Veerle M. H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients Tekijä Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients Tekijä Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis Tekijä Greuter, Marjolein J E, Berkhof, Johannes, Fijneman, Remond J A, Demirel, Erhan, Lew, Jie-Bin, Meijer, Gerrit A, Stoker, Jaap, Coupé, Veerle M H

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data Tekijä Jongeneel, Gabrielle, Klausch, Thomas, van Erning, Felice N., Vink, Geraldine R., Koopman, Miriam, Punt, Cornelis J.A., Greuter, Marjolein J.E., Coupé, Veerle M.H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study Tekijä Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Twisk, Jos W. R., Koopman, Miriam, Punt, Cornelis J. A., Vink, Geraldine R., Coupé, Veerle M. H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Early cost-effectiveness analysis of risk-based selection strategies for adjuvant treatment in stage II colon cancer: the potential value of prognostic molecular markers Tekijä Jongeneel, Gabrielle, Greuter, Marjolein J.E., Kunst, Natalia, van Erning, Felice N., Koopman, Miriam, Medema, Jan P., Vermeulen, Louis, Ijzermans, Jan N.M., Vink, Geraldine R., Punt, Cornelis J.A., Coupé, Veerle M.H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study Tekijä van Wifferen, Francine, de Jonge, Lucie, Worthington, Joachim, Greuter, Marjolein J.E., Lew, Jie-Bin, Nadeau, Claude, van den Puttelaar, Rosita, Feletto, Eleonora, Yong, Jean H.E., Lansdorp-Vogelaar, Iris, Canfell, Karen, Coupé, Veerle M.H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN) Tekijä Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Medema, Jan P., Kandimalla, Raju, Goel, Ajay, Bujanda, Luis, Meijer, Gerrit A., Fijneman, Remond J. A., van Oijen, Martijn G. H., Ijzermans, Jan, Punt, Cornelis J. A., Vink, Geraldine R., Coupé, Veerle M. H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti